Table 1.
GSEA analyses of CTD-2228K2.7, HOTAIRM1 and NCF1C
CTD-2228K2.7 | KEGG name | NES | NOM p-val | FDR q-val |
systemic lupus erythematosus | −1.9380207 | 0.005928854 | 0.0488711 | |
leishmania infection | −1.9338785 | 0.012096774 | 0.0346511 | |
hematopoietic cell lineage | −1.9176999 | 0.004 | 0.0313945 | |
type i diabetes mellitus | −1.9036341 | 0.007984032 | 0.0292524 | |
natural killer cell mediated cytotoxicity | −1.8832018 | 0.01622718 | 0.0298049 | |
HOTAIRM1 | ||||
lysosome | 2.0215623 | 0 | 0.0222536 | |
n glycan biosynthesis | 1.9878095 | 0 | 0.017478 | |
vibrio cholerae infection | 1.880461 | 0 | 0.0592255 | |
amino sugar and nucleotide sugar metabolism | 1.8698859 | 0.00409836 | 0.0526439 | |
proteasome | 1.8244344 | 0.001968504 | 0.0674427 | |
propanoate metabolism | −1.9495336 | 0 | 0.0645897 | |
vascular smooth muscle contraction | −1.9222941 | 0 | 0.0507997 | |
inositol phosphate metabolism | −1.8443166 | 0.005791506 | 0.0843508 | |
lysine degradation | −1.8133465 | 0.008230452 | 0.08976 | |
valine leucine and isoleucine degradation | −1.7961998 | 0.004081633 | 0.0849993 | |
NCF1C | lysosome | 2.0150259 | 0 | 0.0132608 |
n glycan biosynthesis | 1.923236 | 0.001976285 | 0.0407005 | |
amino sugar and nucleotide sugar metabolism | 1.909916 | 0 | 0.0345147 | |
vibrio cholerae infection | 1.9047865 | 0 | 0.028172 | |
proteasome | 1.8770373 | 0.005535055 | 0.0341476 | |
propanoate metabolism | −1.959569 | 0 | 0.0707392 | |
vascular smooth muscle contraction | −1.9155267 | 0.00409836 | 0.0590163 | |
valine leucine and isoleucine degradation | −1.8557318 | 0 | 0.0803684 | |
inositol phosphate metabolism | −1.8172265 | 0.008064516 | 0.0900969 | |
lysine degradation | −1.8166823 | 0.002016129 | 0.0722303 |